195 related articles for article (PubMed ID: 22039075)
1. Monitoring tobacco-specific N-nitrosamines and nicotine in novel Marlboro and Camel smokeless tobacco products: findings from Round 1 of the New Product Watch.
Stepanov I; Biener L; Knezevich A; Nyman AL; Bliss R; Jensen J; Hecht SS; Hatsukami DK
Nicotine Tob Res; 2012 Mar; 14(3):274-81. PubMed ID: 22039075
[TBL] [Abstract][Full Text] [Related]
2. Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch.
Stepanov I; Biener L; Yershova K; Nyman AL; Bliss R; Parascandola M; Hatsukami DK
Nicotine Tob Res; 2014 Aug; 16(8):1070-8. PubMed ID: 24604020
[TBL] [Abstract][Full Text] [Related]
3. Increased pouch sizes and resulting changes in the amounts of nicotine and tobacco-specific N-nitrosamines in single pouches of Camel Snus and Marlboro Snus.
Stepanov I; Jensen J; Biener L; Bliss RL; Hecht SS; Hatsukami DK
Nicotine Tob Res; 2012 Oct; 14(10):1241-5. PubMed ID: 22259150
[TBL] [Abstract][Full Text] [Related]
4. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
Stepanov I; Jensen J; Hatsukami D; Hecht SS
Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
[TBL] [Abstract][Full Text] [Related]
5. Chemical characterization of domestic oral tobacco products: total nicotine, pH, unprotonated nicotine and tobacco-specific N-nitrosamines.
Lawler TS; Stanfill SB; Zhang L; Ashley DL; Watson CH
Food Chem Toxicol; 2013 Jul; 57():380-6. PubMed ID: 23517910
[TBL] [Abstract][Full Text] [Related]
6. High levels of tobacco-specific N-nitrosamines and nicotine in Chaini Khaini, a product marketed as snus.
Stepanov I; Gupta PC; Dhumal G; Yershova K; Toscano W; Hatsukami D; Parascandola M
Tob Control; 2015 Dec; 24(e4):e271-4. PubMed ID: 25217658
[TBL] [Abstract][Full Text] [Related]
7. Chemical analysis of snus products from the United States and northern Europe.
Lawler TS; Stanfill SB; Tran HT; Lee GE; Chen PX; Kimbrell JB; Lisko JG; Fernandez C; Caudill SP; deCastro BR; Watson CH
PLoS One; 2020; 15(1):e0227837. PubMed ID: 31940415
[TBL] [Abstract][Full Text] [Related]
8. Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.
Kotlyar M; Hertsgaard LA; Lindgren BR; Jensen JA; Carmella SG; Stepanov I; Murphy SE; Hecht SS; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):91-100. PubMed ID: 21068204
[TBL] [Abstract][Full Text] [Related]
9. High-Intensity Sweeteners in Alternative Tobacco Products.
Miao S; Beach ES; Sommer TJ; Zimmerman JB; Jordt SE
Nicotine Tob Res; 2016 Nov; 18(11):2169-2173. PubMed ID: 27217475
[TBL] [Abstract][Full Text] [Related]
10. Assessment of mouth-level exposure to tobacco constituents in U.S. snus consumers.
Caraway JW; Chen PX
Nicotine Tob Res; 2013 Mar; 15(3):670-7. PubMed ID: 22990227
[TBL] [Abstract][Full Text] [Related]
11. Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products.
Song MA; Marian C; Brasky TM; Reisinger S; Djordjevic M; Shields PG
Toxicol Lett; 2016 Mar; 245():68-77. PubMed ID: 26802282
[TBL] [Abstract][Full Text] [Related]
12. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study.
Andersson G; Björnberg G; Curvall M
J Oral Pathol Med; 1994 Apr; 23(4):161-7. PubMed ID: 8046653
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.
Richter P; Hodge K; Stanfill S; Zhang L; Watson C
Nicotine Tob Res; 2008 Nov; 10(11):1645-52. PubMed ID: 18988077
[TBL] [Abstract][Full Text] [Related]
14. Consumption patterns and biomarkers of exposure in cigarette smokers switched to Snus, various dissolvable tobacco products, Dual use, or tobacco abstinence.
Krautter GR; Chen PX; Borgerding MF
Regul Toxicol Pharmacol; 2015 Mar; 71(2):186-97. PubMed ID: 25549549
[TBL] [Abstract][Full Text] [Related]
15. Public education about the relative harm of tobacco products: an intervention for tobacco control professionals.
Biener L; Nyman AL; Stepanov I; Hatsukami D
Tob Control; 2014 Sep; 23(5):385-8. PubMed ID: 23481906
[TBL] [Abstract][Full Text] [Related]
16. Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines.
Stanfill SB; Connolly GN; Zhang L; Jia LT; Henningfield JE; Richter P; Lawler TS; Ayo-Yusuf OA; Ashley DL; Watson CH
Tob Control; 2011 May; 20(3):e2. PubMed ID: 21109685
[TBL] [Abstract][Full Text] [Related]
17. Constituent Variations in Smokeless Tobacco Purchased in Mumbai, India.
Stepanov I; Gupta PC; Parascandola M; Yershova K; Jain V; Dhumal G; Hatsukami DK
Tob Regul Sci; 2017 Jul; 3(3):305-314. PubMed ID: 34734108
[TBL] [Abstract][Full Text] [Related]
18. Tobacco-specific nitrosamines in smokeless tobacco products marketed in India.
Stepanov I; Hecht SS; Ramakrishnan S; Gupta PC
Int J Cancer; 2005 Aug; 116(1):16-9. PubMed ID: 15756678
[TBL] [Abstract][Full Text] [Related]
19. Oral tobacco products: preference and effects among smokers.
Hatsukami DK; Jensen J; Anderson A; Broadbent B; Allen S; Zhang Y; Severson H
Drug Alcohol Depend; 2011 Nov; 118(2-3):230-6. PubMed ID: 21515003
[TBL] [Abstract][Full Text] [Related]
20. Is low-nicotine Marlboro snus really snus?
Foulds J; Furberg H
Harm Reduct J; 2008 Feb; 5():9. PubMed ID: 18304348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
